MXPA97006205A - Process for the preparation of olefi - Google Patents
Process for the preparation of olefiInfo
- Publication number
- MXPA97006205A MXPA97006205A MXPA/A/1997/006205A MX9706205A MXPA97006205A MX PA97006205 A MXPA97006205 A MX PA97006205A MX 9706205 A MX9706205 A MX 9706205A MX PA97006205 A MXPA97006205 A MX PA97006205A
- Authority
- MX
- Mexico
- Prior art keywords
- substituted
- aryl
- formula
- alkyl
- vinyl
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 48
- 238000006243 chemical reaction Methods 0.000 claims abstract description 33
- 150000001875 compounds Chemical class 0.000 claims abstract description 32
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 25
- 125000001072 heteroaryl group Chemical group 0.000 claims abstract description 20
- 229910052763 palladium Inorganic materials 0.000 claims abstract description 19
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims abstract description 19
- 239000001257 hydrogen Substances 0.000 claims abstract description 18
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 18
- 230000027455 binding Effects 0.000 claims abstract description 17
- 239000003446 ligand Substances 0.000 claims abstract description 17
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims abstract description 17
- 125000003118 aryl group Chemical group 0.000 claims abstract description 16
- 125000001624 naphthyl group Chemical group 0.000 claims abstract description 15
- 230000000875 corresponding Effects 0.000 claims abstract description 14
- 125000003107 substituted aryl group Chemical group 0.000 claims abstract description 14
- 239000003054 catalyst Substances 0.000 claims abstract description 13
- 125000004435 hydrogen atoms Chemical group [H]* 0.000 claims abstract description 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 10
- 125000005223 heteroarylcarbonyl group Chemical group 0.000 claims abstract description 10
- 125000003435 aroyl group Chemical group 0.000 claims abstract description 9
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims abstract description 8
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011541 reaction mixture Substances 0.000 claims abstract description 8
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims abstract description 7
- 125000001589 carboacyl group Chemical group 0.000 claims abstract description 6
- 125000004414 alkyl thio group Chemical group 0.000 claims abstract description 5
- 125000005843 halogen group Chemical group 0.000 claims abstract description 5
- 125000000547 substituted alkyl group Chemical group 0.000 claims abstract description 5
- 125000002877 alkyl aryl group Chemical group 0.000 claims abstract description 4
- 125000005418 aryl aryl group Chemical group 0.000 claims abstract description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims abstract description 4
- 239000000460 chlorine Substances 0.000 claims abstract description 3
- 229910052801 chlorine Inorganic materials 0.000 claims abstract description 3
- 239000011630 iodine Chemical group 0.000 claims abstract description 3
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical group II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims abstract description 3
- 229910052740 iodine Inorganic materials 0.000 claims abstract description 3
- 150000002894 organic compounds Chemical class 0.000 claims abstract 3
- 150000002940 palladium Chemical class 0.000 claims abstract 3
- -1 vinyl compound Chemical class 0.000 claims description 74
- 150000002148 esters Chemical class 0.000 claims description 10
- UGFAIRIUMAVXCW-UHFFFAOYSA-N carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 claims description 9
- 229910002091 carbon monoxide Inorganic materials 0.000 claims description 9
- 150000001336 alkenes Chemical class 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 150000003839 salts Chemical group 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 238000007792 addition Methods 0.000 claims description 4
- VTMSSJKVUVVWNJ-UHFFFAOYSA-N 1-ethenyl-4-(2-methylpropyl)benzene Chemical compound CC(C)CC1=CC=C(C=C)C=C1 VTMSSJKVUVVWNJ-UHFFFAOYSA-N 0.000 claims description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims 2
- 229910002092 carbon dioxide Inorganic materials 0.000 claims 2
- 239000001569 carbon dioxide Substances 0.000 claims 2
- MRCAAFFMZODJBP-UHFFFAOYSA-N 1-fluoro-3-phenylbenzene Chemical group FC1=CC=CC(C=2C=CC=CC=2)=C1 MRCAAFFMZODJBP-UHFFFAOYSA-N 0.000 claims 1
- 239000005977 Ethylene Substances 0.000 description 30
- VGGSQFUCUMXWEO-UHFFFAOYSA-N ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 30
- 239000000203 mixture Substances 0.000 description 21
- 235000019441 ethanol Nutrition 0.000 description 19
- YOCIJWAHRAJQFT-UHFFFAOYSA-N 2-bromo-2-methylpropanoyl bromide Chemical compound CC(C)(Br)C(Br)=O YOCIJWAHRAJQFT-UHFFFAOYSA-N 0.000 description 16
- 239000002253 acid Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 238000004817 gas chromatography Methods 0.000 description 12
- 229910000856 hastalloy Inorganic materials 0.000 description 12
- 208000002551 Irritable Bowel Syndrome Diseases 0.000 description 11
- 125000004432 carbon atoms Chemical group C* 0.000 description 11
- 150000002941 palladium compounds Chemical class 0.000 description 11
- ILSQBBRAYMWZLQ-UHFFFAOYSA-N N-(1,3-benzothiazol-2-ylsulfanyl)-N-propan-2-ylpropan-2-amine Chemical compound C1=CC=C2SC(SN(C(C)C)C(C)C)=NC2=C1 ILSQBBRAYMWZLQ-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 150000004820 halides Chemical class 0.000 description 7
- 239000005749 Copper compound Substances 0.000 description 6
- 150000001880 copper compounds Chemical class 0.000 description 6
- 125000004122 cyclic group Chemical group 0.000 description 6
- 229910052751 metal Inorganic materials 0.000 description 6
- 239000002184 metal Substances 0.000 description 6
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 6
- OZAIFHULBGXAKX-UHFFFAOYSA-N precursor Substances N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 238000006473 carboxylation reaction Methods 0.000 description 5
- 125000001188 haloalkyl group Chemical group 0.000 description 5
- 150000002431 hydrogen Chemical class 0.000 description 5
- ORTQZVOHEJQUHG-UHFFFAOYSA-L Copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 4
- 229910002666 PdCl2 Inorganic materials 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 4
- 229910052736 halogen Inorganic materials 0.000 description 4
- 150000002367 halogens Chemical class 0.000 description 4
- 229960001680 ibuprofen Drugs 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N iso-propanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 239000001301 oxygen Substances 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 4
- 229910052717 sulfur Inorganic materials 0.000 description 4
- 239000011593 sulfur Substances 0.000 description 4
- 238000006886 vinylation reaction Methods 0.000 description 4
- VSCWAEJMTAWNJL-UHFFFAOYSA-K Aluminium chloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N Formic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N HCl Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 3
- 102000014961 Protein Precursors Human genes 0.000 description 3
- 108010078762 Protein Precursors Proteins 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N acetic acid ethyl ester Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 125000004183 alkoxy alkyl group Chemical group 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 3
- 230000003197 catalytic Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 3
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 3
- 229960002009 naproxen Drugs 0.000 description 3
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- BDERNNFJNOPAEC-UHFFFAOYSA-N propanol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 3
- XBDQKXXYIPTUBI-UHFFFAOYSA-N propionic acid Chemical compound CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- AYFJBMBVXWNYLT-UHFFFAOYSA-N 2-bromo-6-methoxynaphthalene Chemical compound C1=C(Br)C=CC2=CC(OC)=CC=C21 AYFJBMBVXWNYLT-UHFFFAOYSA-N 0.000 description 2
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L Copper(II) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- SBZXBUIDTXKZTM-UHFFFAOYSA-N Diglyme Chemical compound COCCOCCOC SBZXBUIDTXKZTM-UHFFFAOYSA-N 0.000 description 2
- QPJVMBTYPHYUOC-UHFFFAOYSA-N Methyl benzoate Chemical compound COC(=O)C1=CC=CC=C1 QPJVMBTYPHYUOC-UHFFFAOYSA-N 0.000 description 2
- CMWTZPSULFXXJA-VIFPVBQESA-N Naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- 229910052786 argon Inorganic materials 0.000 description 2
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 239000004305 biphenyl Substances 0.000 description 2
- 235000010290 biphenyl Nutrition 0.000 description 2
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium monoxide Chemical compound [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 2
- 150000001733 carboxylic acid esters Chemical class 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- QMQBBUPJKANITL-MYXGOWFTSA-N dextropropoxyphene hydrochloride Chemical class [H+].[Cl-].C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 QMQBBUPJKANITL-MYXGOWFTSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 125000005842 heteroatoms Chemical group 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- 239000012433 hydrogen halide Substances 0.000 description 2
- 229910000039 hydrogen halide Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N n-butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 description 2
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- YXFVVABEGXRONW-UHFFFAOYSA-N toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 2
- ZMANZCXQSJIPKH-UHFFFAOYSA-N triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 2
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 1
- YYXRTDFUOREJJF-UHFFFAOYSA-N 1-(2-methylpropyl)-4-[2-[4-(2-methylpropyl)phenyl]ethenyl]benzene Chemical compound C1=CC(CC(C)C)=CC=C1C=CC1=CC=C(CC(C)C)C=C1 YYXRTDFUOREJJF-UHFFFAOYSA-N 0.000 description 1
- PLDWAJLZAAHOGG-UHFFFAOYSA-N 1-bromo-3-methoxybenzene Chemical compound COC1=CC=CC(Br)=C1 PLDWAJLZAAHOGG-UHFFFAOYSA-N 0.000 description 1
- BVBHVVRVSMBCPW-UHFFFAOYSA-N 1-bromo-4-(2-methylpropyl)benzene Chemical group CC(C)CC1=CC=C(Br)C=C1 BVBHVVRVSMBCPW-UHFFFAOYSA-N 0.000 description 1
- WCIFVXNIHUSTHF-UHFFFAOYSA-N 1-bromopropane Chemical group [CH2]CCBr WCIFVXNIHUSTHF-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- BYLAWYTWAYOBDP-UHFFFAOYSA-N 1-chlorobutane Chemical group [CH2]CCCCl BYLAWYTWAYOBDP-UHFFFAOYSA-N 0.000 description 1
- YZNQITSGDRCUKE-UHFFFAOYSA-N 1-chloropropane Chemical group [CH2]CCCl YZNQITSGDRCUKE-UHFFFAOYSA-N 0.000 description 1
- NVJUHMXYKCUMQA-UHFFFAOYSA-N 1-ethoxypropane Chemical compound CCCOCC NVJUHMXYKCUMQA-UHFFFAOYSA-N 0.000 description 1
- FNQIWGMVIKVMPH-UHFFFAOYSA-N 1-fluorobutane Chemical group [CH2]CCCF FNQIWGMVIKVMPH-UHFFFAOYSA-N 0.000 description 1
- HNEGJTWNOOWEMH-UHFFFAOYSA-N 1-fluoropropane Chemical group [CH2]CCF HNEGJTWNOOWEMH-UHFFFAOYSA-N 0.000 description 1
- 125000004206 2,2,2-trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- 125000004778 2,2-difluoroethyl group Chemical group [H]C([H])(*)C([H])(F)F 0.000 description 1
- ICKWGFYFODTQTL-UHFFFAOYSA-N 2-(2-fluoro-4-phenylphenyl)propanoic acid Chemical compound C1=C(F)C(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 ICKWGFYFODTQTL-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N 2-(6-methoxynaphthalen-2-yl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- XNLICIUVMPYHGG-UHFFFAOYSA-N 2-Pentanone Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 description 1
- 125000001340 2-chloroethyl group Chemical group [H]C([H])(Cl)C([H])([H])* 0.000 description 1
- DGQUMYDUFBBKPK-UHFFFAOYSA-N 2-ethenyl-6-methoxynaphthalene Chemical compound C1=C(C=C)C=CC2=CC(OC)=CC=C21 DGQUMYDUFBBKPK-UHFFFAOYSA-N 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 description 1
- FDPIMTJIUBPUKL-UHFFFAOYSA-N 3-Pentanone Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 description 1
- MNOJRWOWILAHAV-UHFFFAOYSA-N 3-bromophenol Chemical compound OC1=CC=CC(Br)=C1 MNOJRWOWILAHAV-UHFFFAOYSA-N 0.000 description 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 description 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 description 1
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N AI2O3 Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- FPHLBGOJWPEVME-UHFFFAOYSA-N Alminoprofen Chemical compound OC(=O)C(C)C1=CC=C(NCC(C)=C)C=C1 FPHLBGOJWPEVME-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 101700060963 CBT1 Proteins 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N Carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- POLCUAVZOMRGSN-UHFFFAOYSA-N Dipropyl ether Chemical compound CCCOCCC POLCUAVZOMRGSN-UHFFFAOYSA-N 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N Flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 238000007341 Heck reaction Methods 0.000 description 1
- RJMIEHBSYVWVIN-UHFFFAOYSA-N Indoprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1N1C(=O)C2=CC=CC=C2C1 RJMIEHBSYVWVIN-UHFFFAOYSA-N 0.000 description 1
- PHTQWCKDNZKARW-UHFFFAOYSA-N Isoamyl alcohol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N Ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 101710022515 MADS50 Proteins 0.000 description 1
- 239000007832 Na2SO4 Substances 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N Oraflex Chemical compound N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- INIOZDBICVTGEO-UHFFFAOYSA-L Palladium(II) bromide Chemical compound Br[Pd]Br INIOZDBICVTGEO-UHFFFAOYSA-L 0.000 description 1
- PIDSZXPFGCURGN-UHFFFAOYSA-N Pirprofen Chemical compound ClC1=CC(C(C(O)=O)C)=CC=C1N1CC=CC1 PIDSZXPFGCURGN-UHFFFAOYSA-N 0.000 description 1
- TVQZAMVBTVNYLA-UHFFFAOYSA-N Pranoprofen Chemical compound C1=CC=C2CC3=CC(C(C(O)=O)C)=CC=C3OC2=N1 TVQZAMVBTVNYLA-UHFFFAOYSA-N 0.000 description 1
- KRIOVPPHQSLHCZ-UHFFFAOYSA-N Propiophenone Chemical compound CCC(=O)C1=CC=CC=C1 KRIOVPPHQSLHCZ-UHFFFAOYSA-N 0.000 description 1
- 101700086089 SOC1 Proteins 0.000 description 1
- 229960004492 Suprofen Drugs 0.000 description 1
- MDKGKXOCJGEUJW-UHFFFAOYSA-N Suprofen Chemical compound C1=CC(C(C(O)=O)C)=CC=C1C(=O)C1=CC=CS1 MDKGKXOCJGEUJW-UHFFFAOYSA-N 0.000 description 1
- ITMCEJHCFYSIIV-UHFFFAOYSA-N Trifluoromethanesulfonic acid Chemical compound OS(=O)(=O)C(F)(F)F ITMCEJHCFYSIIV-UHFFFAOYSA-N 0.000 description 1
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N Triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical group 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229960004663 alminoprofen Drugs 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 230000000202 analgesic Effects 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 1
- 125000004104 aryloxy group Chemical group 0.000 description 1
- 229960005430 benoxaprofen Drugs 0.000 description 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 238000005893 bromination reaction Methods 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- 125000005997 bromomethyl group Chemical group 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000001805 chlorine compounds Chemical class 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 229910052570 clay Inorganic materials 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004850 cyclobutylmethyl group Chemical group C1(CCC1)C* 0.000 description 1
- 125000000582 cycloheptyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 125000006622 cycloheptylmethyl group Chemical group 0.000 description 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000004851 cyclopentylmethyl group Chemical group C1(CCCC1)C* 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000003111 delayed Effects 0.000 description 1
- HFPGRVHMFSJMOL-UHFFFAOYSA-N dibromomethane Chemical group Br[CH]Br HFPGRVHMFSJMOL-UHFFFAOYSA-N 0.000 description 1
- 125000006003 dichloroethyl group Chemical group 0.000 description 1
- XTHFKEDIFFGKHM-UHFFFAOYSA-N dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- KONIYTHNVWYBMP-UHFFFAOYSA-N ethylcyclohexane Chemical group [CH2-]C[C+]1CCCCC1 KONIYTHNVWYBMP-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 125000004216 fluoromethyl group Chemical group [H]C([H])(F)* 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 239000002638 heterogeneous catalyst Substances 0.000 description 1
- 239000008079 hexane Substances 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- KLGZELKXQMTEMM-UHFFFAOYSA-N hydride Chemical compound [H-] KLGZELKXQMTEMM-UHFFFAOYSA-N 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-N hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 1
- 125000002883 imidazolyl group Chemical group 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 229960004187 indoprofen Drugs 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 125000002346 iodo group Chemical group I* 0.000 description 1
- KPJPHPFMCOKUMW-UHFFFAOYSA-N iodomethane Chemical group I[CH2] KPJPHPFMCOKUMW-UHFFFAOYSA-N 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229960002373 loxoprofen Drugs 0.000 description 1
- BAZQYVYVKYOAGO-UHFFFAOYSA-M loxoprofen sodium hydrate Chemical compound O.O.[Na+].C1=CC(C(C([O-])=O)C)=CC=C1CC1C(=O)CCC1 BAZQYVYVKYOAGO-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 229940095102 methyl benzoate Drugs 0.000 description 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- AMQJEAYHLZJPGS-UHFFFAOYSA-N n-pentanol Chemical class CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- VZWAWVSXPBYNPC-UHFFFAOYSA-N octane-1-thiolate Chemical group [CH2+]CCCCCCC[S-] VZWAWVSXPBYNPC-UHFFFAOYSA-N 0.000 description 1
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 230000003287 optical Effects 0.000 description 1
- 125000002971 oxazolyl group Chemical group 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 229960000851 pirprofen Drugs 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229960003101 pranoprofen Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 235000019260 propionic acid Nutrition 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000003226 pyrazolyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003440 styrenes Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000005346 substituted cycloalkyl group Chemical group 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N sulfonic acid Chemical compound OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 230000002194 synthesizing Effects 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 150000003738 xylenes Chemical class 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
Abstract
The present invention relates to a process, characterized in that it comprises the preparation of an olefinic compound corresponding to the formula C (R3) (R4) = C (R2) A by reaction of an organic compound having the formula AX with a compound vinyl or substituted vinyl having the C (R3) (R4) = C (R2) H in the presence of a catalyst containing (a) palladium or palladium salt and (b) a ligand corresponding to the formula: activated reaction mixture containing a substantial amount of said olefinic compound: in these formulas A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl or substituted vinyl, R2, R3 and R4 are independently selected from hydrogen, alkyl, cycloalkyl, substituted alkyl of cycloalkyl, aryl, substituted aryl alkoxy, alkylthio, heteroaryl, substituted heteroaryl, alkanoyl, aroyl, substituted aroyl, heteroarylcarbonyl, substituted heteroarylcarbonyl, trifluoromethyl and halo; X is chlorine, bromine, iodine or diazonium, Ar is phenyl, substituted phenyl, naphthyl or substituted naphthyl, R 'and R "are independently selected from hydrogen, alkyl, aryl or substituted aryl, and n is an integer of
Description
PROCESS FOR THE PREPARATION OF QLEPHINS
FIELD OF THE INVENTION The invention relates to a method for the preparation of substituted olefins by means of palladium catalyst coupled to vinyl compounds with organic halides and the subsequent preparation of carboxylic acids or esters.
Ante? Qdenteg Palladium-catalyzed vinylation of organic halides provides a very convenient method for the formation of carbon-carbon bonds in unsubstituted vinyl positions. The reaction, reported by Heck (Palladium
Reasents in Organnic Syntheses. Academic Press, Canada 1985) can be used to prepare fine organics, pharmaceuticals, and especially monomers. For example, the reaction allows a one-step synthesis of substituted aryl bromide esters and is an excellent method for the preparation of a wide variety of styrene derivatives.
Heitz et al., Makromol Chem. 1 £ 2, 119 (1968). A new process for preparing aliphatic carboxylic acids substituted with aryl or their alkyl esters is provided in U.S. Pat. No. 5,315,026. A substituted 1-aryl olefin reacts with carbon monoxide in REF: 25366
presence of water or an alcohol at a temperature between 25 ° C and 200 ° C. A mixture of palladium compound and a copper compound with a stable acidic cyclic phosphine having the formula:
where R 'is the same or different than R "and is hydrogen, alkyl or aryl, said aryl, substituted or unsubstituted, and Ar is phenyl, naphthyl, substituted phenyl or substituted naphthyl and n is an integer from 3 to 6 used as a catalyst.
Description of Preferred Modes Definitions In the following specification the meaning of the substituent groups is as follows: "alkyl" means straight or branched alkyl chain having from 1 to 20 carbon atoms and includes, for example, methyl, ethyl, propyl , isopropyl, butyl, isobutyl, secondary butyl, tertiary butyl, pentyl, isopentyl, neopentyl, hexyl, octyl, 2-ethylhexyl, 1, 1, 3, 3, -tetrametilbutilo, nonyl, decyl, dodecyl, tetradecyl, heptadecyl, octadecyl and eicosyl, (for the purposes of this definition, "alkyl" could be replaced by "aliphatic." This term includes "Cs alkyls" which is 1 to 6 linear carbon atoms.
or branched); "cycloalkyl" means cyclic alkyl having 3 to 7 carbon atoms and includes, e.g. ex. cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl and cycloheptyl; "aryl" means phenyl, naphthyl or biphenyl; "substituted aryl" means phenyl, naphthyl, or biphenyl substituted by at least one substituent selected from the group consisting of aryl (as defined above), halogen (chloro, bromo, fluoro or iodo), amino, nitro, hydroxy, alkyl, alkoxy (which means straight or branched chain alkoxy having from 1 to 10 carbon atoms, and includes, for example, methoxy, ethoxy, propoxy, isopropoxy, butoxy, isobutoxy, secondary butoxy, tertiary butoxy, pentyloxy, isopentyloxy, hexyloxy, heptyloxy , octyloxy, nonyloxy, decyloxy), aryloxy including phenoxy and phenoxy substituted with halo, alkyl, or alkoxy, haloalkyl which means straight or branched chain alkyl having from 1 to 8 carbon atoms which are substituted by at least one halogen, and includes, for example, chloromethyl, bromomethyl, fluoromethyl, iodomethyl, 2-chloroethyl, 2-bromomethyl, 2-fluoromethyl, 3-chloropropyl, 3-bromopropyl, 3-fluoropropyl, 4-chlorobutyl, 4-fluorobutyl, dichloroethyl, dibromomethyl, diflu romethyl, diiodomethyl, 2,2-dichloroethyl, 2,2-dibromoethyl, 2,2-difluoroethyl, 3,3-dichloropropyl, 3,3-difluoropropyl, 4,4-dichlorobutyl, 4,4-difluorobutyl, trichlororaethyl,
trifluoromethyl, 2, 2, 2-trifluoroethyl, 2,3,3-trifluoropropyl, 1, 1,2, 2-tetrafluoroethyl and 2,2,3,3-tetrafluoropropyl; "substituted cycloalkyl alkyl" means that the cycloalkyl compound is cyclic alkyl having 3 to 7 carbon atoms and the alkyl compound is straight or branched chain alkyl having 1 to 8 carbon atoms and includes, for example, cyclopropylmethyl, cyclobutylmethyl, cyclopentylmethyl, cyclohexylmethyl, cycloheptylmethyl, 2-cyclopropylethyl, 2-cyclopentylethyl, 2-cyclohexylethyl, 3-cyclopropylpropyl, 3-cyclohexylpropyl, 4-cyclopropylbutyl, 4-cyclopentylbutyl, 4-cyclohexylbutyl, 6-cyclopropylhexyl and 6-cyclohexylhexyl; "alkylthio" means a sulfur divalent with alkyl occupying one of the valences and includes the groups methylthio, ethylthio, propylthio, butylthio, pentthylthio, hexylthio and octylthio;
"heteroaryl" means 5 to 10 mono- or fused-hetero-aromatic rings having at least one heteroatom and includes those selected from the group consisting of nitrogen, oxygen and sulfur, and includes, for example, 2-furyl, 3-furyl, 2-dienyl, 3-thienyl, 2-pyridyl, 3-pyridyl, 4-pyridyl, pyrazolyl, imidazolyl, pyrimidinyl, pyridazinyl, pyrazinyl, benzimidazolyl, quinolyl, oxazolyl, thiazolyl and indolyl; "substituted heteroalyl" means 5 to 10 mono-
or fused-hetero-aromatic having at least one heteroaromatic selected from a group consisting of nitrogen, oxygen and sulfur and which is substituted by at least one substituent selected from a group consisting of halogen, amino, nitro, hydroxy, alkyl, alkoxy and haloalkyl in the aforementioned heteroaromatic nucleus; "alkanoyl" means alkanoyl having from 2 to 18 carbon atoms and includes, for example, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, valeryl, haxanoyl, octanoyl, lauroyl and stearoyl; "Aroyl" means benzoyl or naphthoyl; "substituted aroyl" means benzoyl or naphthoyl substituted by at least one substituent including those selected from a group consisting of halogen, amino, nitro, hydroxy, alkyl, alkoxy and haloalkyl in the benzene and naphthalene ring; "heteroarylcarbonyl" means that the heteroaryl compound is 5 to 10 mono- or fused-heteroaromatic rings having at least one heteroatom and includes those selected from the group consisting of nitrogen, oxygen and sulfur as mentioned above, and includes, example, furoyl, tinoyl, nicotinoyl, isonicotinoyl, pyrazolylcarbonyl, imidazolylcarbonyl, pyrimidinylcarbonyl and benzimidazolylcarbonyl;
"substituted heteroarylcarbonyl" means the aforementioned heteroarylcarbonyl which is substituted by at least one substituent selected from a group consisting of halogen, amino, nitro, hydroxy, alkoxy and haloalkyl in the heteroaryl nucleus; and includes, for example, 2-oxo-l, 3-dioxollan-4-ylmethyl, or 2-oxo-l, 3-dioxan-5-yl; "vinyl" means an unsaturated substituent having at least one unsaturated double bond and having the formula CH, = CH-; "substituted vinyl" means the above vinyl substituent having at least one of the protons at the terminal carbon atom replaced with alkyl, cycloalkyl, substituted alkyl of cycloalkyl, aryl, substituted aryl, heteroaryl or substituted heteroaryl. In one of the embodiments of the present invention, olefin compounds are produced having the formula:
where R2, R3 and R are the same or different and are individually hydrogen, alkyl, cycloalkyl, substituted alkyl cycloalkyl, substituted or unsubstituted aryl, alkoxy, alkylthio, substituted or unsubstituted heteroalyl, alkanoyl, substituted or unsubstituted aroyl,
unsubstituted or substituted heteroarylcarbonyl, trifluoromethyl or halo, and A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl or substituted vinyl. Preferably, in the compounds of formula II, A is substituted or unsubstituted aryl, R 2, R 3 and R "are hydrogen, from Ci to Cs alkyl, phenyl or substituted or unsubstituted trifluoromethyl. More preferably A is phenyl substituted with alkyl (eg, isobutyl) or naphthyl substituted with alkoxy (eg, methoxy), R 2, R 3 and R * are hydrogen, methyl or trifluoromethyl, especially hydrogen. The compounds of Formula II are produced by reaction of an organic halide of Formula AX where X is chlorine, bromine, iodine, diazonium, triflate, or other leaving groups found in organic texts, and A as defined above, with a vinyl or substituted vinyl compound of the formula RJ l = c / RR_H where R, R3 and R "are as previously defined. The reaction, sometimes called the "vinylation" reaction, is carried out in the presence of a reaction promoter catalyst which is palladium metal or palladium compound (Pd) with Pd of valence 0, 1 or 2 and a cyclic ligand of formula
(
where R 'and R "are the same or different and are individually hydrogen, alkyl, aryl or substituted aryl, Ar is phenyl, naphthyl, substituted phenyl or substituted naphthyl and n is an integer from 3 to 6. Preferably R1 and R" are the same or different and are alkyl of a Cß, Ar is phenyl or naphthyl and n is 3 or 4. More preferably R * is methyl or ethyl, R "is a branched alkyl of Cx to Cs, Ar is phenyl and n is 4. Preferred especially neomentildiphenyl-phosphine co or cyclic ligand The vinylation reaction is carried out in the presence or in the absence of a solvent When a solvent is used, it may be a polar solvent such as, for example, acetonitrile, tetrahydrofuran, dioxane or dimethylformamide.
The conditions for the vinylation reaction usually require an equimolar ratio of organic halide to vinyl or substituted vinyl compound, although an excess of vinyl compound is preferred. The catalyst / ligand ratio is typically used in a ratio of 1 mol of organic halide to 0.0005 mol of palladium or palladium compound. The cyclic ligand is present in the same or greater molar ratio as the metal or metal compound. It should be noted that levels of palladium metal or palladium compound and ligand can be substantially higher (up to 10 times). When relatively inactive vinyl or halide species are found, for example, highly substituted olefins and / or
Strongly stable organic halides substituents that donate electrons may require these high amounts of catalyst / ligand. The reaction temperatures are very moderate, varying between 25 ° C to 200 ° C (preferably 60 ° C to 150 ° C) with pressures (for gaseous vinyl compounds) being from atmospheric to 3000 psi (preferably 400 to 1000 psi) . With the improved catalyst combination of the present invention, the reaction times are unusually short, typically giving the complete reaction between 1 to 24 hours, typically 2 to 4 hours. Higher temperatures and pressures tend to cause decomposition of reagents and olefin products and this should be avoided. The olefin formed in the reaction mixture is easily separated by conventional methods, e.g. ex. , distillation or extraction with a non-polar solvent, p. ex. , liquid hydrocarbons such as hexane having from 5 to 12 carbon atoms both linear or branched. A further embodiment of the present invention is one in which the olefin compound of Formula II can be used with or without isolation (preferably without isolation) of the reaction mixture in the catalytic carboxylation step to produce compounds of Formula III
where RL, R2, R3, R «and A are as previously defined.
The catalytic carboxylation of the compound of Formula II is carried out, at a temperature between 25 ° C and 200 ° C, preferably of 25"- 120 ° C, and more preferably 25 ° - 100 ° C. High temperatures can also be used. has found that a small performance advantage is obtained by gradually increasing the temperature in the preferred range during the course of the reaction.The partial pressure of the carbon monoxide in the reaction vessel is at least one atmosphere (0 psig). ) at room temperature (or the temperature at which the container is fed) Some higher carbon monoxide pressures may be used up to the pressure limits of the reaction apparatus A pressure up to about 3000 psig is desirable in the process. is a pressure of 0 to 3000 psig at the reaction temperature and more preferred is a reaction of 0 to 1000 psig It should be noted that the presence of oxygen is undesirable in the reaction n hydrocarboxylation of this invention. Because of this, a 100% atmosphere of carbon monoxide is preferred for
carry out this process. Several inert gases (eg, nitrogen and argon) can, however, be incorporated into the reaction mass, the only criterion being that the process should not be delayed at the point requiring exceptionally long periods to complete the reaction. Carboxylation is carried out in the presence of at least one mole of water or aliphatic alcohol per mole of the compound of Formula II; however, an excess is preferred to aid in driving the entire reaction. Although there is no actual upper limit for the amount of water or alcohol except that imposed by practice (eg the size of the reaction vessel), an amount of up to about 100 moles per mole of the compounds of Formula II is useful in the process. Furthermore, controlling the amount of water or alcohol used in the process of this invention is advantageous in terms of producing higher yields. Accordingly, an amount of 1 to 50 moles of water or alcohol per mole of the compounds of Formula II is preferred, and an amount of 2 to 24 moles of water or alcohol per mole of such olefinic compound is more preferred. The product of the reaction is a carboxylic acid (where Rt is hydrogen) or carboxylic acid ester (where Ri is alkyl) of Formula III. The present invention encompasses any individual racemate and optical isomers of the compounds of Formula
III that have a chiral carbon atom. For example, when the compounds of Formula III wherein the acid is 2- (6-methoxy-2-naphthyl) propionic acid, they are subjected to resolution as set forth in U.S. Pat. 4,246,164, the analgesic compound naproxen is produced. Any alcohol that produces an ester of the carboxylic acid could be used in the practice of this invention. In a preferred embodiment, aliphatic alcohols Cj are used. to C «. Examples of the alcohols to be used in this embodiment include methyl alcohol, ethyl alcohol, n-propyl alcohol, isopropyl alcohol, n-, iso-, sec-, and tert-butyl alcohols, pentyl alcohols, (isoamine alcohol, especially form the naproxen ester), and the hexyl alcohols. Methyl alcohol is highly preferred, and methyl alcohol is much preferred. Other alcohols, glycols, or aromatic hydroxy compounds could also be used. In the broadest sense, these alcohols provide a source of alkoxide ions for this reaction. However, any other "alkoxide ion source" could also be used. The source of such ions is a compound selected from the group consisting of HCOROR, (R) 2C (ORx) a, HC (0) ORlf BÍOR ,, Ti (0Rx) 4, Al (0Rt) 3 where R is hydrogen or individually the same or different than Rt and Ri is as previously defined. In a preferred embodiment of this invention, the
carboxylation reaction is initiated under neutral conditions, e.g. ex. , without adding acid. It can also develop in the presence of an acid addition. When the acids are added, such acids include sulfuric acid, phosphoric acid or sulfonic acid. A hydrogen halide acid such as hydrochloric or hydrobromic acid is preferred. The hydrogen halide could be added in the gas phase or in the liquid phase. Any concentration could be used. Hydrochloric acid is particularly preferred, in a concentration of up to 10%; more preferred is a concentration of 10% to 30%. The amount of acid added is such that it provides up to 40 moles of hydrogen ion per mole of the compound of Formula II; more preferred is an amount to provide up to 10 moles of hydrogen ion per mole of the compound; the most preferred amount provides up to 4 moles of hydrogen ion per mole of the compounds of Formula II. The catalytic carboxylation process of this invention is carried out in the presence of an amount that promotes the reaction of (i) palladium metal or palladium compounds in which the palladium has a valence of zero, 1 or 2, or (ii) a mixture of palladium or palladium compound and a copper compound, with (iii) the cyclic ligand of Formula I. The palladium and copper compounds are sometimes referred to as palladium and copper salts.
In one embodiment, the palladium and copper compounds are inorganic salts and are added as a preformed complex of, for example, palladium (II) chloride or bromide, copper (II) chloride or bromide and carbon monoxide or any other complex Similary. In a preferred embodiment, the active catalyst species are formed in situ by the addition to the reaction mixture of the individual components, e.g. ex. , a ligand, a copper compound and a palladium compound such as the inorganic salts of palladium (II) and copper (II). These inorganic salts include chlorides, bromides, nitrates, sulfates or acetates. In the most preferred embodiment, neomentildiphenylphosphine, copper (II) chloride and palladium (II) chloride are used and are added individually or together, simultaneously or sequentially. The metallic palladium or the palladium compound of the mixture of palladium and copper compounds can be supported on carbon, silica, alumina, zeolite, clay, other polymeric materials and used as heterogeneous catalysts. The amount of the mixture of copper and palladium or palladium metal compounds or their compounds preferably employed is such as to provide from 4 to 8000 moles of the compound of Formula II per mole of the metal or metal salt mixture. More preferable, 1 to 40 moles of
ligand per mole of the mixture, and more preferably 1 to 20 moles of the ligand are used per mole of the mixture. The presence of a solvent in the process of this invention is not required, although it may be desirable in some circumstances. Solvents that can be used include one or more of the following: ketones, for example, acetone, methyl ethyl ketone, diethyl ketone, methyl n-propyl ketone and acetophenone; linear, poly and cyclic esters, for example, diethyl ether, di-n-propyl ether, di-n-butyl ether, ethyl n-propyl ether, glime (ethylene glycol dimethyl ether), diglyme (diethylene glycol dimethyl ether) , tetrahydrofuran, dioxane and 1,3-dioxolane; and aromatic hydrocarbons, for example, toluene, ethylbenzene and xylenes. Alcohols are also suitable as solvents, for example, methanol, ethanol, 1-propanol, 2-propanol, isomers of butanol and isomers of pentanol. Acids and esters, such as formic or acetic acid or ethyl acetate, could also be used. When an ester or alcohol is used as a solvent, the product is the corresponding ester of the carboxylic acid. More highly preferred are the ethers, especially tetrahydrofuran. When solvents are used, the amount can be up to 100 mL per gram of the compounds of Formula II, but the process is more advantageously carried out in the presence of 1 to 30 mL per gram of the compound of Formula II.
In the preferred embodiments of this invention in which an ester is produced, e.g. ex. alkyl ibuprofen ester, the ester could conveniently be converted to the acid (the same ibuprofen) by conventional methods of hydrolysis. The hydrolysis base can also be employed if it is desired to produce pharmaceutically acceptable salts wherein the cation is sodium, potassium, calcium, acid carbonate or a quaternary ammonium compound. Examples of compounds produced by the use of this invention include ibuprofen; 2- (6-methoxy-2-naphthiDpropionic acid; 2- (3-fluoro-4-biphenylyl) -propionic acid
(also known as flurbiprofen) and 2- (3-bezoylphenyl) propionic acid (also known as ketoprofen).
As described herein the bromine precursor of each of the above compounds reacts with ethylene in the presence of a base (e.g., triethylamine) and a palladium catalyst
(as described herein, including a ligand such as neomentildiphenylphosphine). The base should be selected to avoid beta hydride removal under reaction conditions and should not react with the olefin or bromine precursor to any appreciable degree. The bromine precursor substituted by ethylene provides the substituted olefin which is then carboxylated (using carbon monoxide and palladium catalyst as described herein) to produce the corresponding acid product (if the water is part or
is all the system solvent) or the corresponding ester (if an alcohol such as methyl, ethyl or isoamyl alcohol) is used as all or part of the solvent. The above reactions can be exemplified as follows: 1BUPROPENO
FLURBIPROBßHO
CETOPROPHENE
© nrj, ...., -c? Qfc H = C H. CO
C H COOH
NAPROXEN
ROXENO
PHENOPROPHENE
In the above reactions the ethylene pressure should be 50 to 3000 psi (preferably 400 to 1000 psi), the temperature is 30QC to 200ßC (preferably 60 °C to 150ßC). The temperatures and pressures are selected to minimize the decomposition of olefin. Palladium '* "is used in the form of its salts (eg, acetate or chloride) together with a ligand as described with the preferred phosphine ligands.
Bromine precursors are often commercially available and / or can be easily prepared by art practices. For example, Aldrich Chemical Company sells m-bromophenol and m-bromoanisole while Albermale PCC (Paris, France) sells 6-methoxy-2-bromonaphthalene. Ibuprofen bromide precursors can be prepared by methylbenzoate bromination (or a similar minor hydrocarbon ester) using aluminum chloride followed by hydrolysis of NaOH, conversion to acid chloride (e.g., with SOC1,) and reaction with benzene (again, using a Friedel-Crafts catalyst such as A1C13). In addition to the prophene compounds described above, other prophene compounds that can be prepared by the use of this invention to convert to the corresponding bromine precursors by means of the reaction with ethylene include protic acid, thiaprofenic acid, indoprofen, benoxaprofen, carprofen, pirprofen, pranoprofen, alminoprofen, suprofen and loxoprofen. The following examples are given to illustrate the process of this invention and it is not intended to do so as a limitation thereof.
EXAMPLES
NMDP = Neomentildiphenylphosphine
IBS = 4-Isobutylstyrene BIBB = 4-Bromoisobutylbenzene DIBE a i,? -Bis (4-isobutylphenyl) ethylene DIBS = 4,4'-Diisobutylstilbene
Example i Pd (OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0.100 g, 0.308 mmol) were loaded in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (280 psig). The mixture was stirred at 120-125CC for 2 h. The GC analysis of an aliquot showed IBS (95.5% of the area), DIBE (0.6%), and DIBS (4.0%).
Example 2. Pd (OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0.100 g, 0.308 mmol) were charged in an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (320 pßig). The mixture was stirred at 100-105 ° C for 2 h. The GC analysis of an aliquot showed IBS
(97.6% of the area), DIBE (0.1%), and DIBS (2.4%).
Bj? I? Pln 1 Pd (OAc) 2 (11.0 mg, 0.0490 mmol) and NMDP (0.100 g, 0.308 mmol) were loaded in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB
(10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (330 psig). The mixture was stirred at 80-85 ° C for 4 h. The GC analysis of an aliquot showed IBS
(97.9% of the area) and DIBS (2.0%).
Example 4 (Comparative) Pd (0Ac) 2 (11.0 mg, 0.0490 mmol) and (o-Tol) 3P (94.0 mg, 0.309 mmol) were loaded in an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the deck. CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (330 psig). The mixture was stirred at 80-85 ° C for 8 h. The GC analysis of an aliquot showed IBS (24.0% of the area), BIBB (76.0%), and DIBS (trace).
Example 5 (ComparatiYQ-Pd (OAc) 2 (11.0 mg, 0.0490 mmol) and (Cyclohexyl) 3P (87.0 mg, 0.310 mmol) were loaded in an autoclave (Hastelloy B, 100 mL) in a dry box. in the dry box and mounted on the cover CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (300 psig) .The mixture was stirred at 80-85eC for 8 h.The GC analysis of an aliquot showed no reaction.
Example 6 (CgnparatiyjpJ.Pd (OAc) 2 (11.0 mg, 0.0490 mmol) and Ph3P (81.0 mg, 0.309 mmol) were loaded in an autoclave (Hastelloy B, 100 raL) in a dry box The reactor was assembled in the box dried and mounted on the cover CH3CN (12.5 mL), Et3 N (12.5 mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (320 psig) The mixture was stirred at 80-85 ° C and monitored by GC, Bl GC analysis of an aliquot in 8 h showed IBS (14.4% GC area), BIBB (84.6%), and DIBS (trace) .
yjffipifi 7 Pd (OAc) 2 (5.0 mg, 0.022 mmol) and NMDP (45 mg, 0.14 mmol)
were loaded in an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (14 mL), Et3 N (14 mL) and BIBB (11.8 g, 55 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (280 psig). The mixture was stirred at 100-105CC for 4 h. The GC analysis of an aliquot showed IBS (97.8% of the area) and dimers (2.2%).
Example 8 PdCl2 (9.0 mg, 0.0510 mmol) and NMDP (0.100 g, 0.308 mmol) were charged in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (12.5 mL), Et, N (12.5 mL) and BIBB (10.7 g, 50.2 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (300 psig). The mixture was stirred at 80-85 ° C for 4 h. The GC analysis of an aliquot showed IBS (98.2% of the area), DIBE (0.1%), and DIBS (1.6%).
Using 9 PdCl2 (9.0 mg, 0.0510 mmol) and NMDP (0.100 g, 0.308 mmol), CaO (1.5 g, 26.7 mmol) were loaded in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. DMF (30
mL) and BIBB (10.6 g, 49.7 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (360 psig). The mixture was stirred at 80-85 ° C for 6 h. The GC analysis of an aliquot showed IBS (95.9% of the area), BIBB (2.0%), DIBE (0.1%), and DIBS (2.1%).
Example 1Q PdCl2 (9.0 mg, 0.0510 mmol) and NMDP (0.100 g, 0.308 mmol) were charged in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. DMF (20 mL), Et3 N (7.5 mL) and BIBB (10.7 g, 50.2 mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (300 psig). The mixture was heated to 80-85 ° C and the reactor was pressurized with ethylene at 520 psig. The mixture was stirred at this temperature for 2.5 h. The GC analysis of an aliquot showed IBS (97.5% of the area), DIBE (0.1%), and DIBS (2.5%).
Example n PdCl2 (7.0 mg, 0.0395 mmol) and NMDP (0.130 g, 0.401 mmol) were charged in an autoclave (Hastelloy C, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. DMF (15 mL), Bt3 N (10.2 g) and BIBB (21.0 g, 98.5
mmol) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (300 psig). The mixture was stirred at 120 ° C for 1 h. The GC analysis of an aliquot showed IBS (92.0% of the area), BIBB (0.4%), DIBE (0.7%) and DIBS (6.9%).
B-Example 12 Pd (OAc) 2 (11.0 mg, 0.0490 mmol), NMDP (0.100 g, 0.308 mmol), and 2-bromo-6-methoxynaphthalene (11.8 g, 49.8 mmol) were loaded in an autoclave (Hastelloy B, 100 mL) in a dry box. The reactor was assembled in the dry box and mounted on the cover. CH3CN (20 mL) and Et3 N (8 mL) were added via syringe. The reactor was purged with ethylene (2x150 psig) and then filled with ethylene (320 pßig). The mixture was stirred at 80-85 ° C for 5 h. The GC analysis showed only 2-methoxy-6-vinylnaphthalene. The reaction mixture was cooled to room temperature and the ethylene pressure was released. The mixture was filtered and the precipitate was washed with CHjClj (150 mL). The combined filtrate was washed with HC1 (1N, 2x50 mL), H20 (50 mL), and brine (50 mL). The organic film was dried (Na2SO4) and concentrated under reduced pressure to give a white solid (8.76 g, 96%): mp »92-9 ° C.
Claims (9)
- Claims l. A process, characterized in that it comprises the preparation of an olefinic compound corresponding to the formula C (R3) (R4) = C (R2) A by reaction of an organic compound having the formula AX with a vinyl or substituted vinyl compound having C (R3) (R = C (R2) H in the presence of a catalyst containing (a) palladium or palladium salt and (b) a ligand corresponding to the formula: to form an activated reaction mixture containing a substantial amount of said olefinic compound; in these formulas A is aryl, substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl, or substituted vinyl; R2, R, and R, are independently selected from hydrogen, alkyl, cycloalkyl, substituted alkyl of cycloalkyl, aryl, substituted aryl, alkoxy, alkylthio, heteroaryl, substituted heteroaryl, alkanoyl, aroyl, substituted aroyl, heteroarylcarbonyl, substituted heteroarylcarbonyl, triforomethyl and halo; X is chlorine, bromine, iodine or diazonium; Ar is phenyl, phenyl substituted, naphthyl or substituted naphthyl; R 'and R "are independently selected from hydrogen, alkyl, aryl or substituted aryl, and n is an integer of 3-6 2. The process of claim 1, characterized in that the palladium component of the catalyst is a salt of Pd ** and the ligand is neomentildiphenylphosphine. 3. The process of claim 1, characterized in that A is substituted or unsubstituted aryl and R2, R3 and R4 are independently selected from hydrogen, alkyl containing 1-6 carbons, trifluoromethyl, and substituted or unsubstituted phenyl. The process of claim 3, characterized in that A is isobutylphenyl, methoxynaphthyl, 3-fluorobiphenyl, 3-phenoxyphenyl or 3-benzoylphenyl; and each of R2, R3 and R4 is hydrogen. 5. The process of claim 4, characterized in that A is isobutylphenyl. 6. The process of claim 4, characterized in that A is methoxynaphthyl. The process of any of the preceding claims including the further step of reacting said olefinic compound with carbon monoxide to convert it into a carboxylic compound corresponding to the formula CH (R3) (R4) -C (R2) (A) -C (O) -ORt, characterized in that Rx is hydrogen or alkyl. 8. The process of claim 7, characterized in that the reaction with carbon monoxide is carried out by the addition of carbon dioxide and an aliphatic alcohol to the reaction mixture containing said olefinic compound as well as to form an ester corresponding to the Formula CH (R3) (R «) -C (R2) (A) -C (0) -0R1 # characterized in that Rx is alkyl. The process of claim 7, characterized in that the reaction with carbon monoxide is carried out by the addition of carbon dioxide and a water to the reaction mixture containing said olefinic compound as well as to form an ester corresponding to the formula CH (R3) (R4) -C (R2) (A) -C (O) -ORlf characterized in that Rt is hydrogen. PROCESS FOR THE PREPARATION OF OLEFINS SUMMARY OF THE INVENTION 4-Isobutylstyrene and other olefinic compounds corresponding to the formula C (R3) (R4) = C (R2) A were prepared by reacting an organic compound having the formula AX with a vinyl or substituted vinyl compound having C (R3) (R = C (R2) H in the presence of a catalyst containing (a) palladium or palladium salt and (b) a ligand corresponding to formula (I) in this formula A is aryl , substituted aryl, heteroaryl, substituted heteroaryl, benzyl, substituted benzyl, vinyl, or substituted vinyl; R3, R3 and R4 are independently selected from hydrogen, alkyl, cycloalkyl, substituted alkyl of cycloalkyl, aryl, substituted aryl, alkoxy, alkylthio, heteroaryl , substituted heteroaryl, alkanoyl, aroyl, substituted aroyl, heteroarylcarbonyl, substituted heteroarylcarbonyl, trifluoromethyl and halo; X is chloro, bromo, iodo or diazonium; Ar is phenyl, substituted phenyl, naphthyl or substituted naphthyl; R 'and R "are independently selected preferably hydrogen, alkyl, aryl or substituted aryl; and n is an integer of 3-6. The olefinic compounds by the reaction could be carbonylated to the corresponding carboxylic compounds. R 'A ~ C H-P (A r), fc? V CH-R
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/390,466 US5536870A (en) | 1995-02-17 | 1995-02-17 | Process for preparing olefins |
US08390466 | 1995-02-17 | ||
PCT/US1996/001754 WO1996025376A1 (en) | 1995-02-17 | 1996-02-08 | Process for preparing olefins |
Publications (2)
Publication Number | Publication Date |
---|---|
MX9706205A MX9706205A (en) | 1997-10-31 |
MXPA97006205A true MXPA97006205A (en) | 1998-07-03 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5536870A (en) | Process for preparing olefins | |
EP0961765B1 (en) | Preparation of carboxylic compounds and their derivatives | |
US5315026A (en) | Process for preparing aryl-substituted aliphatic carboxylic acids and their esters using cyclic phosphine catalysts | |
US5482596A (en) | Mixed ligand catalyst for preparing aryl-substituted aliphatic carboxylic esters | |
US5254720A (en) | Process for preparing aryl-substituted aliphatic carboxylic acids and their alkyl esters | |
US6096920A (en) | Preparation of carboxylic compounds and their derivatives | |
CA1338592C (en) | Process for the carbonylation of arylalkyl halides | |
MXPA97006205A (en) | Process for the preparation of olefi | |
US6080888A (en) | Preparation of olefinic compounds and carboxylic derivatives thereof | |
US5315028A (en) | Olefinic process for preparing aryl-substituted aliphatic carboxylic esters | |
US5322959A (en) | Catalytic carboxylation process for preparing aryl-substituted aliphatic carboxylic esters | |
EP0741684B1 (en) | Process for preparing carboxylic acids by carbonylation of ethers and thioethers | |
US5315030A (en) | Catalytic carbonylation of ethers and thioethers | |
EP0535682B1 (en) | Preparation of aryl-substituted olefins | |
US6049005A (en) | Process to prepare a pentenoic acid anhydride |